文摘
Development of an industrial process for3-(cyclopentyloxy)-N-(3,5-dichloropyrid-4-yl)-4-methoxybenzamide, a potentPDEIV type inhibitor, is described. The rapid identificationofscalable reaction conditions allowed pilot-scale synthesisofkilogramme quantities for early clinical evaluation.However,as more compound was demanded, better reaction conditionswere required in the interests of safety, economics, andenvironmental impact. This led to the derivation of ahigh-yielding and very robust procedure which included varioussafeguards to ensure that high-quality product wasobtainedand that new trace impurities were effectively removed.Thelarge-scale oxidation of a benzaldehyde derivative to thecorresponding benzoic acid using hydrogen peroxide underaqueous alkaline conditions is described.